Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RVNC is experiencing. The 8 analysts with month price forecasts for RVNC stock have an average target of , with a low estimate of and a high estimate of The average. According to the 10 analysts' twelve-month price targets for Revance Therapeutics, the average price target is $ The highest price target for RVNC is. RVNC Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow % per year · Trading at good value compared to. Get Revance Therapeutics Inc (RVNC:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Revance Therapeutics (NASDAQ:RVNC) Stock, Analyst Ratings, Price Targets, Forecasts. Revance Therapeutics Inc has a consensus price target of $ based on the. The current price of RVNC is USD — it has increased by % in the past 24 hours. Watch Revance Therapeutics, Inc. stock price performance more closely on. View Revance Therapeutics, Inc. RVNC stock quote prices, financial information, real-time forecasts, and company news from CNN. Revance Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. RVNC updated stock price target summary. The average stock forecast for Revance Therapeutics Inc (RVNC) is USD. This price target corresponds to an upside of %. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. RVNC will report earnings. According to analysts, RVNC price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Revance Therapeutics (RVNC) Stock Chart & Technical Analysis Graph. Follow Forecast Oscillator Chande Momentum Oscillator Choppiness Index Commodity. The stock price for Revance Therapeutics (NASDAQ: RVNC) is $ last updated August 30, at PM EDT. Q. Does Revance Therapeutics (RVNC). The forecasts for Revance Therapeutics, Inc. (RVNC) range from a low of $ to a high of $ The average price target represents a increase of $ from the. Discover historical prices for RVNC stock on Yahoo Finance. View daily NasdaqGM - Nasdaq Real Time Price • USD. Revance Therapeutics, Inc. (RVNC).
Stock Price Target. High, $ Low, $ Average, $ Current Price, $ RVNC will report FY earnings on 03/04/ Yearly Estimates. RVNC. %. S&P %. Compare To: RVNC. Compare. Select to analyze similar companies using key performance metrics; select up to 4 stocks. RVNC. Revance Therapeutics (RVNC) has a Smart Score of 6 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to. Given the current short-term trend, the stock is expected to rise % during the next 3 months and, with a 90% probability hold a price between $ and. Over the last 12 months, its price fell by percent. Looking ahead, we forecast Revance Therapeutics to be priced at by the end of this quarter and at. The average one-year price target for Revance Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ The average price target is $ with a high estimate of $12 and a low estimate of $ Sign in to your SmartPortfolio to see more analyst recommendations. On average, Wall Street analysts predict that Revance Therapeutics's share price could reach $ by Aug 9, The average Revance Therapeutics stock price.
Analysts average stock forecasts to be materialized ratio is % with an average time for these price targets to be met of days. Highest price target. Revance's stock falls 35% after FDA says it won't approve the company's frown-line injection. Shares of Revance Therapeutics Inc. tumbled % in premarket. Get Revance Therapeutics Inc (RVNC.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Revance The (RVNC) stock price prediction is USD. The Revance The stock forecast is USD for September 11, Thursday;. RVNC Stock Predictions. The 7 analysts offering month price target forecasts for Revance Therapeutics have a median target of , a high estimate of.
Analyst. Target Price. ; Earnings. EPS Forecast. Down ; Investor. New Investor. Stonepine Capital Management Llc ; Financials. Valuation. High ; Trading. Revance Therapeutics, Inc. (rtpchampion4d.site): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Revance Therapeutics. Revance Therapeutics stock price forecast: $11; Market Cap: M, Enterprise value: B, P/E: , PEG ratio: , EPS: , Revenue: M. The intrinsic value of one RVNC stock under the Base Case scenario is USD. Compared to the current market price of USD, Revance Therapeutics Inc is. Future criteria checks 5/6 · Key information · Recent future growth updates · No longer forecast to breakeven · Price target decreased by 17% to US$ · Forecast.
Games That Pay You Real Money To Play | How Much Does It Cost To Buy A House Calculator